Stock-Based Compensation (Tables)

12 Months Ended

Jan. 31, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Components of Stock-based Compensation Expense

The components of stock-based compensation expense recognized in the consolidated statements of operations consisted of the following (in thousands):

	Year Ended January 31,
	2024		2023
Cost of revenue	$	17,187	$	10,093
Research and development	61,055		51,771
Sales and marketing	55,798		40,115
General and administrative	83,890		62,487
Restructuring	(1,060)		—
Total	$	216,870	$	164,466

Nonvested Restricted Stock Shares Activity

A summary of our RSU and PSU activity is as follows:

	Number of Shares	Weighted-Average Grant Date Fair Value
Outstanding as of January 31, 2023	14,409,166	$	27.37
Granted	22,822,240	17.17
Released	(6,021,877)	25.15
Forfeited	(3,803,072)	22.17
Outstanding as of January 31, 2024	27,406,457	$	20.08

Share-based Payment Arrangement, Option, Activity

A summary of our stock option activity is as follows:

	Number of Options	Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value (in thousands)
Outstanding as of January 31, 2023	32,446,814	$	4.71	6.52	$	337,214
Granted	—	—
Exercised	(10,298,114)	2.75
Forfeited	(988,850)	5.60
Outstanding as of January 31, 2024	21,159,850	$	5.63	6.25	$	447,989
Expected to vest as of January 31, 2024	21,159,850	$	5.63	6.25	$	447,989
Vested and exercisable as of January 31, 2024	15,633,560	$	4.51	5.96	$	348,522

Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions

The following table summarizes the assumptions used in estimating the fair value of employee stock purchase rights using the Black-Scholes option pricing model for the periods presented:

	Year Ended January 31,
	2024		2023
Expected term (in years)	0.5		0.5 - 1.0
Expected volatility	55% - 85%		72% - 96%
Risk-free interest rate	5.2% - 5.5%		2.6% - 4.8%
Dividend yield	—	%	—	%